Highly iodinated intravenous contrast material for PET/CT - a feasibility study.

PURPOSE Intravenous contrast materials (CM) are of benefit in PET/CT imaging. However, CM may influence tracer quantification and may cause artifacts when using the CT data for PET attenuation correction. The aim of the study was to assess the feasibility of applying a highly concentrated CM (HCCM, 400 mg iodine/ml) in PET/CT in comparison to a lower concentrated CM (LCCM, 300 mg iodine/ml). MATERIALS AND METHODS In 60 whole-body FDG PET/CT scans (30 scans each with HCCM and LCCM), tracer uptake (maximal standardized uptake value - SUVmax) and CT attenuation (Hounsfield Units) were quantified at 16 positions in different vessels and parenchyma. The number of potential PET artifacts was documented. The Mann-Whitney-Wilcoxon Test was performed for statistical assessment (p < 0.05). RESULTS HCCM did not cause a significant increase in the SUVmax (p > 0.05) or the number of PET artifacts (p = 0.69) while simultaneously significantly increasing CT attenuation (p = 0.002) as compared to LCCM in 11 / 16 positions. CONCLUSION The application of HCCM seems feasible in PET/CT and should be considered in future protocols.

[1]  D. Sahani,et al.  Evaluation of renal transplant donors with 16-section multidetector CT angiography: comparison of contrast media with low and high iodine concentrations. , 2007, Journal of vascular and interventional radiology : JVIR.

[2]  C. Claussen,et al.  Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. , 2007, The British journal of radiology.

[3]  C. Claussen,et al.  Vergleich verschiedener Atem- und Kontrastmittelprotokolle bezüglich Bild- und Koregistrierungsqualität bei 18F-FDG-PET/CT-Untersuchungen , 2007 .

[4]  Joong-Won Park,et al.  [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma]. , 2006, The Korean journal of hepatology.

[5]  J. Coya,et al.  PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  D. Sahani,et al.  Comparison of Enhancement, Image Quality, Cost, and Adverse Reactions Using 2 Different Contrast Medium Concentrations for Routine Chest CT on 16-Slice MDCT , 2006, Journal of computer assisted tomography.

[7]  M. Kanematsu,et al.  MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. , 2006, AJR. American journal of roentgenology.

[8]  J. Bucerius,et al.  Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients , 2006 .

[9]  Johannes Czernin,et al.  Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Tinsu Pan,et al.  Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. , 2006, AJR. American journal of roentgenology.

[11]  Roland Bares,et al.  Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  S. Holm,et al.  PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  K. Awai,et al.  MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations. , 2005, AJR. American journal of roentgenology.

[14]  M. Kanematsu,et al.  Optimizing Scan Delays of Fixed Duration Contrast Injection in Contrast-Enhanced Biphasic Multidetector-Row CT for the Liver and the Detection of Hypervascular Hepatocellular Carcinoma , 2005, Journal of computer assisted tomography.

[15]  T. Beyer,et al.  Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  P. Vernon,et al.  Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Katsuyoshi Ito,et al.  Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. , 2004, AJR. American journal of roentgenology.

[18]  Thomas Beyer,et al.  Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. , 2004, Radiology.

[19]  Thomas Beyer,et al.  Acquisition protocol considerations for combined PET/CT imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Thomas Beyer,et al.  To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  J. Debatin,et al.  Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging. , 2003, Investigative radiology.

[22]  D. Fleischmann.  Use of high-concentration contrast media in multiple-detector-row CT: principles and rationale , 2003, European Radiology.

[23]  D. Fleischmann,et al.  High-concentration contrast media in MDCT angiography: principles and rationale , 2003, European Radiology.

[24]  Yuji Nakamoto,et al.  Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies. , 2003, Radiology.

[25]  D. Fleischmann.  Use of high concentration contrast media: principles and rationale-vascular district. , 2003, European journal of radiology.

[26]  R. Wahl,et al.  Initial experience with oral contrast in PET/CT: phantom and clinical studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Thomas Beyer,et al.  Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  Gerald Antoch,et al.  Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Kazuo Awai,et al.  Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. , 2002, Radiology.

[30]  W. Pegios,et al.  Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. , 2000, Radiology.

[31]  Paul Kinahan,et al.  Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.